Literature DB >> 15016617

Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus.

Ann Marie LeVine1, James Elliott, Jeffrey A Whitsett, Anon Srikiatkhachorn, Erika Crouch, Nihal DeSilva, Thomas Korfhagen.   

Abstract

Surfactant protein (SP)-D gene targeted (SP-D-/-) and wild-type mice were infected with respiratory syncytial virus (RSV) by intratracheal instillation. Decreased clearance of RSV was observed in SP-D-/- mice. Deficiency of SP-D was associated with increased inflammation and inflammatory cell recruitment in the lung after infection. In vitro, SP-D bound RSV-infected Vero cells. Binding was inhibited with ethylenediamine tetraacetic acid and maltose, suggesting that the carbohydrate recognition domain of SP-D recognizes RSV glycoproteins in a calcium-dependent manner. SP-D bound specifically to the RSV proteins G and F. Phagocytosis of RSV by alveolar macrophages was reduced in the absence of SP-D in vivo, and SP-D enhanced phagocytosis of RSV by alveolar macrophages and neutrophils but not peritoneal macrophages in vitro. Oxygen radical production by alveolar macrophages from SP-D+/+ and SP-D-/- mice was decreased after RSV infection, and SP-D ameliorated the inhibitory effects of RSV on oxygen radical production by macrophages and neutrophils in vitro. Because the airway is the usual portal of entry for RSV and other respiratory pathogens, the local production of SP-D is likely to play a role in innate defense responses to inhaled viruses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016617     DOI: 10.1165/rcmb.2003-0107OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  64 in total

Review 1.  Collectins and cationic antimicrobial peptides of the respiratory epithelia.

Authors:  B Grubor; D K Meyerholz; M R Ackermann
Journal:  Vet Pathol       Date:  2006-09       Impact factor: 2.221

2.  Dipeptidyl peptidase I controls survival from Klebsiella pneumoniae lung infection by processing surfactant protein D.

Authors:  Rachel E Sutherland; Sophia S Barry; Joanna S Olsen; D Brenda Salantes; George H Caughey; Paul J Wolters
Journal:  Biochem Biophys Res Commun       Date:  2014-06-21       Impact factor: 3.575

3.  Differential expression of ovine innate immune genes by preterm and neonatal lung epithelia infected with respiratory syncytial virus.

Authors:  Kenji Kawashima; David K Meyerholz; Jack M Gallup; Branka Grubor; Tatjana Lazic; Howard D Lehmkuhl; Mark R Ackermann
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

4.  Phosphatidylinositol inhibits respiratory syncytial virus infection.

Authors:  Mari Numata; Pitchaimani Kandasamy; Yoji Nagashima; Rachel Fickes; Robert C Murphy; Dennis R Voelker
Journal:  J Lipid Res       Date:  2015-01-05       Impact factor: 5.922

5.  Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection.

Authors:  Mari Numata; Hong Wei Chu; Azzeddine Dakhama; Dennis R Voelker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 6.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 7.  Pulmonary surfactant: an immunological perspective.

Authors:  Zissis C Chroneos; Zvjezdana Sever-Chroneos; Virginia L Shepherd
Journal:  Cell Physiol Biochem       Date:  2009-12-22

8.  Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response.

Authors:  Fatoumata B Sow; Jack M Gallup; David K Meyerholz; Mark R Ackermann
Journal:  Dev Comp Immunol       Date:  2009-02-02       Impact factor: 3.636

9.  Transmission of surfactant protein variants and haplotypes in children hospitalized with respiratory syncytial virus.

Authors:  Neal J Thomas; Susan DiAngelo; Joseph C Hess; Ruzong Fan; Margaret W Ball; Joseph M Geskey; Douglas F Willson; Joanna Floros
Journal:  Pediatr Res       Date:  2009-07       Impact factor: 3.756

10.  Pharmacological management of acute bronchiolitis.

Authors:  Melvin Wright; Charles J Mullett; Giovanni Piedimonte
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.